Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Clinical Trial ID NCT00272870

PubWeight™ 4.20‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00272870

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 2009 3.32
2 Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection. Blood 2008 1.04
Next 100